Here’s why TMS is a treatment option to consider in obsessive-compulsive disorder.
Scott Blackman
Advertisement
Mr Blackman is the Director of Market Access at BrainsWay.
Articles by Scott Blackman
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Psychiatric Times
1
New 6-Month Data From Second Phase 3 Trial Confirms Rapid Effect of COMP360 for TRD
2
Phase 2 Trial Initiated for Briumvi for Treatment-Resistant Schizophrenia
3
Take-Home Messages: Clinical Confidence in Transitioning Patients to Cobenfy
4
Treating Cannabis Addiction and Withdrawal: Latest Clinical Data
5